The John B. Amos Cancer Center, part of the Columbus Regional Healthcare System, has been recognized as a recipient of the 2012 Commission on Cancer (CoC) Outstanding Achievement Award (OAA). The John B. Amos Cancer Center is one of only three accredited cancer programs in Georgia to receive the award and the state’s only Community Hospital Comprehensive Cancer Center recognized for this achievement.
Seventy-nine cancer programs in the U.S. received this award designed to recognize cancer programs that strive for excellence in providing quality care to cancer patients. Also receiving the award in Georgia were Coliseum Medical Center in Macon and Memorial Health in Savannah.
“We are pleased about the national recognition for our team, technology, quality measures, clinical research and all the other elements that comprise our program,” said Andrew Pippas, M.D., Medical Director and Director of Clinical Oncology Research for the John B. Amos Cancer Center. “Most importantly, this recognition further assures our community that they have access to outstanding cancer care right here in Columbus.”
A facility receives the OAA following the on-site evaluation by a physician surveyor during which the facility demonstrates a Commendation level of compliance with seven standards that represent the full scope of the cancer program and also receives a compliance rating for the remaining 29 standards. The standards that form the basis of the OAA criteria include cancer committee leadership, cancer data management, clinical services, research, community outreach, and quality improvement.
The John B. Amos Cancer Center has been accredited by the American College of Surgeons’ CoC since 1991.
About the John B. Amos Cancer Center
The John B. Amos Cancer Center, a part of Columbus Regional Healthcare System, is the leading cancer treatment facility in Southwest Georgia, offering outpatient medical and radiation oncology, infusion therapy, an oncology pharmacy, and support services for patients and their families. The center reported more than 2,500 new patients during last fiscal year (July 2011-June 2012). There were more than 70,000 total patient visits. The center recorded more than 25,000 patient visits in Medical Oncology, nearly 17,000 in Infusion and more than 26,000 in Radiation Oncology.
About the Commission on Cancer
Established in 1922 by the American College of Surgeons, the Commission on Cancer is a consortium of professional organizations dedicated to improving survival rates and quality of life for cancer patients through standard-setting, prevention, research, education, and the monitoring of comprehensive, quality care. Its membership includes Fellows of the American College of Surgeons and 42 national organizations that reflect the full spectrum of cancer care.
Receiving care at a Commission on Cancer-accredited cancer program ensures that a patient will have access to comprehensive care, including a range of state-of-the-art services and equipment; a multi-specialty, team approach to coordinate the best treatment options; information about ongoing clinical trials and new treatment options; access to cancer-related information, education and support; a cancer registry that collects data on type and state of cancers and treatment results and offers lifelong patient follow-up; ongoing monitoring and improvement of care; quality care close to home.